- JP-listed companies
- SUMITOMO CHEMICAL COMPANY, LIMITED
SUMITOMO CHEMICAL COMPANY, LIMITEDJP:4005
Market cap
¥667.9B
P/E ratio
| Mar 31, 2018 | Mar 31, 2019 | Mar 31, 2020 | Mar 31, 2021 | Mar 31, 2022 | Mar 31, 2023 | Mar 31, 2024 | |
| Profit (loss) before tax | 240,811 | 188,370 | 130,480 | 137,803 | 251,136 | 231 | -462,792 |
| Depreciation and amortization | 107,103 | 112,495 | 131,741 | 136,017 | 156,667 | 167,957 | 157,522 |
| Impairment losses (reversal of impairment losses) | - | 24,639 | 37,328 | 40,833 | 8,111 | 109,417 | 269,389 |
| Share of loss (profit) of investments accounted for using equity method | -55,319 | -37,201 | -9,233 | 12,459 | -42,180 | 6,797 | 57,398 |
| Interest and dividend income | -10,101 | -10,849 | -10,904 | -8,440 | -9,976 | -18,730 | -22,139 |
| Interest expenses | 10,646 | 10,623 | 12,513 | 16,091 | 16,111 | 22,468 | 29,234 |
| Business structure improvement expenses | 14,210 | 9,067 | 7,806 | 6,323 | 10,572 | 22,021 | 48,397 |
| Change in fair value of contingent consideration | -8,383 | -8,950 | -48,475 | -22,463 | -3,282 | -3,388 | 1,562 |
| Loss (gain) on sale of fixed assets | -6,801 | -1,434 | -931 | -18,730 | -718 | -5,226 | -1,215 |
| Decrease (increase) in trade receivables | -24,617 | -26,600 | -10,938 | -22,426 | -19,465 | 134,499 | 34,798 |
| Decrease (increase) in inventories | -55,626 | -35,613 | -11,713 | 12,644 | -98,247 | -79,887 | 78,554 |
| Increase (decrease) in trade payables | 73,607 | -18,673 | -22,048 | 48,270 | -39,188 | -63,628 | -32,251 |
| Increase (decrease) in unearned revenue | - | - | 4,881 | 47,976 | 565 | -13,717 | -11,543 |
| Increase (decrease) in provisions | 10,514 | 4,124 | -8,060 | 16,513 | 15,559 | -13,373 | -50,143 |
| Other | - | 38,041 | -52,303 | 28,094 | -9,620 | -88,340 | -67,240 |
| Subtotal | 297,775 | 245,070 | 145,202 | 430,964 | 236,045 | 177,101 | 29,531 |
| Interest and dividends received | 41,742 | 32,999 | 27,033 | 15,968 | 22,258 | 25,265 | 26,812 |
| Interest paid | -10,534 | -10,940 | -12,733 | -15,860 | -15,404 | -21,768 | -28,060 |
| Income taxes paid | -28,747 | -50,161 | -48,688 | -54,401 | -68,323 | -65,529 | -48,333 |
| Business structure improvement expenses paid | -6,986 | -8,825 | -4,802 | -2,207 | -2,861 | -3,448 | -31,267 |
| Net cash provided by (used in) operating activities | 293,250 | 208,143 | 106,012 | 374,464 | 171,715 | 111,621 | -51,317 |
| Decease (increase) of marketable securities | - | - | - | -2,644 | -7,529 | 6,546 | -3,953 |
| Purchase of non-current assets | -149,207 | -174,816 | -120,449 | -120,812 | -107,467 | -143,581 | -152,873 |
| Proceeds from sales of non-current assets | 10,200 | 4,010 | 1,974 | 24,371 | 2,537 | 18,231 | 1,959 |
| Inflow (outflow) through acquisition of subsidiary | -13,236 | -3,348 | -204,592 | -3,355 | - | -17,174 | -1,019 |
| Purchase of investments | -14,276 | -9,126 | -122,493 | -8,074 | -15,768 | -7,692 | -5,273 |
| Proceeds from sale and redemption of investments | 6,092 | 2,420 | 6,763 | 20,935 | 16,540 | 42,974 | 97,963 |
| Collection of loans receivable | - | - | - | - | 1,296 | 63,199 | 95 |
| Payments for loans receivable | - | - | -1,734 | -81,760 | -1,259 | -1,728 | -67,825 |
| Proceeds from sale of subsidiaries | - | - | - | - | 153 | 30,092 | 20,701 |
| Other | 5,907 | 23 | 1,889 | -6,050 | -2,475 | -10,278 | -2,015 |
| Net cash provided by (used in) investing activities | -154,520 | -180,837 | -499,670 | -177,389 | -115,421 | -19,411 | -112,240 |
| Net increase (decrease) in short-term borrowings | -82,586 | 3,180 | 237,592 | -237,585 | -3,158 | 100,959 | 26,405 |
| Net increase (decrease) in commercial paper | 34,000 | -4,000 | -28,000 | -2,000 | 10,000 | 35,000 | 29,000 |
| Proceeds from long-term borrowings | 81,690 | 89,190 | 67,689 | 202,403 | 46,154 | 66,141 | 67,113 |
| Repayments of long-term borrowings | -58,984 | -67,871 | -85,657 | -58,517 | -77,132 | -109,130 | -39,083 |
| Proceeds from issuance of bonds | 39,790 | 49,725 | 282,575 | 158,734 | 34,808 | - | 39,836 |
| Redemption of bonds | -55,000 | -77,000 | -30,500 | -45,000 | -34,259 | - | -30,000 |
| Repayments of lease liabilities | -3,281 | -3,175 | -14,778 | -15,149 | -15,984 | -16,668 | -18,619 |
| Dividends paid | -27,797 | -37,606 | -35,970 | -19,620 | -31,068 | -42,484 | -19,639 |
| Dividends paid to non-controlling interests | -15,569 | -13,521 | -16,717 | -16,775 | -11,195 | -13,982 | -5,965 |
| Payments for acquisition of interests in subsidiaries from non-controlling interests | -6,588 | -2,205 | -2,622 | -19,396 | -3,999 | -199,073 | - |
| Other | 61 | 2,417 | -70 | 2,090 | 4,439 | 735 | 198 |
| Net cash provided by (used in) financing activities | -94,264 | -60,866 | 373,542 | -39,974 | -81,394 | -178,502 | 49,246 |
| Effect of exchange rate changes on cash and cash equivalents | -5,832 | 3,309 | -914 | 23,169 | 29,611 | 27,842 | 28,736 |
| Net increase (decrease) in cash and cash equivalents | 38,634 | -30,251 | -21,030 | 180,270 | 4,511 | -58,450 | -85,575 |
| Net increase (decrease) in cash and cash equivalents resulting from transfer to assets held for sale | - | - | - | - | - | -1,135 | -2,820 |